Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 125 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Rheumatoid arthritis and lung disease: from mechanisms to a practical approachLake, F.; Proudman, S.
2017Antifibrillarin antibodies are associated with native north American ethnicity and poorer survival in systemic sclerosisOtero, C.; Assassi, S.; Hudson, M.; Mayes, M.; Estrada-Y-Martin, R.; Pedroza, C.; Mills, T.; Walker, J.; Baron, M.; Stevens, W.; Proudman, S.; Nikpour, M.; Mehra, S.; Wang, M.; Fritzler, M.
2016Reduced corticosteroid-binding globulin cleavage in active rheumatoid arthritisNenke, M.; Lewis, J.; Rankin, W.; McWilliams, L.; Metcalf, R.; Proudman, S.; Torpy, D.
2014Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyOwen, C.; Ngian, G.; Moore, O.; Stevens, W.; Proudman, S.; Roddy, J.; Zochling, J.; Nash, P.; Hill, C.; Sturgess, A.; Sahhar, J.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2011Decline in hand bone mineral density indicates increased risk for erosive change in early rheumatoid arthritis (RA)Black, R.; Spargo, L.; Schultz, C.; Chatterton, B.; James, M.; Cleland, L.; Hill, C.; Proudman, S.; Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 52nd Annual Scientific Meeting (14 May 2011 - 17 May 2011 : Brisbane, Qld.)
2012Decline in hand bone mineral density indicates increased risk for erosive change in early rheumatoid arthritis (RA)Black, R.; Spargo, L.; Shultz, C.; Chatteron, B.; James, M.; Cleland, L.; Lester, S.; Hill, C.; Proudman, S.; RACP Future Directions in Health Congress 2012 (06 May 2012 - 09 May 2012 : Brisbane, Qld.)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2014The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisMorrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2012Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosisNgian, G.; Sahhar, J.; Proudman, S.; Stevens, W.; Wicks, I.; Van Doornum, S.
2012An immunochip-based interrogation of scleroderma susceptibility variantsCharlesworth, J.; Stankovich, J.; Lewis, P.; Byron, J.; Stevens, W.; Sahhar, J.; Proudman, S.; Roddy, J.; Nash, P.; Tymms, K.; Brown, M.; Zochling, J.; 2nd Systemic Sclerosis World Congress (02 Feb 2012 - 04 Feb 2012 : Madrid, Spain)